Literature DB >> 9186642

B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity.

R Roth1, R J Gee, M J Mamula.   

Abstract

The exact role of B cells in antigen presentation to naive T cells in vivo is presently not known. Here, we demonstrate the ability of a B cell subset consisting of B7-2pos-B cells to prime autoreactive T cells in B cell-deficient mice. In contrast, B cell-deficient mice are unable to mount a similar initiation and expansion of the autoimmune response. The expression of the B7-2 costimulatory molecule as well as the specificity to a self-antigen, either murine cytochrome c or murine ribonucleoproteins (the target of autoimmunity in SLE), enabled B cells as antigen-presenting cells to induce naive lymph node T cells to proliferate and to express IFN-gamma, IL-4, IL-5, and IL-10 cytokine mRNAs. In contrast, neither adoptively transferred B7-2neg-B cells nor nonspecific B7-2pos-B cells were able to activate naive T cells. In addition, anti-B7-2 treatment prevented the in vivo expression of the IL-4, IL-5, and IFN-gamma cytokine mRNA responses. Our results suggest a major role of autoantigen-specific B7-2pos-B cells in breaking T cell tolerance to self-antigen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186642     DOI: 10.1111/j.1749-6632.1997.tb52047.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.

Authors:  M J Yellin; U Thienel
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

4.  TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.

Authors:  Petar Lenert; Rachel Brummel; Elizabeth H Field; Robert F Ashman
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

5.  Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.

Authors:  John H Wang; Jun Li; Qi Wu; PingAr Yang; Rahul D Pawar; Shutao Xie; Laura Timares; Chander Raman; David D Chaplin; Lu Lu; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE.

Authors:  Matilda W Nicholas; Mary Anne Dooley; Susan L Hogan; Jennifer Anolik; John Looney; Ingnacio Sanz; Stephen H Clarke
Journal:  Clin Immunol       Date:  2008-02       Impact factor: 3.969

7.  Transfer of antigen from human B cells to dendritic cells.

Authors:  Bohdan P Harvey; Maurice T Raycroft; Timothy E Quan; Benjamin J Rudenga; Robert M Roman; Joe Craft; Mark J Mamula
Journal:  Mol Immunol       Date:  2013-12-03       Impact factor: 4.407

8.  B Cell in Autoimmune Diseases.

Authors:  Christiane S Hampe
Journal:  Scientifica (Cairo)       Date:  2012

Review 9.  Lupus autoantigens: their origins, forms, and presentation.

Authors:  H A Doyle; J Yan; B Liang; M J Mamula
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

10.  Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus.

Authors:  Thomas Dörner; Joerg Kaufmann; William A Wegener; Nick Teoh; David M Goldenberg; Gerd R Burmester
Journal:  Arthritis Res Ther       Date:  2006-04-21       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.